BNC-105P

N/A

Report date: 2022/07/28 17:03:52
NME

Base Information

Drug NameBNC-105P
Drug Alias NameBNC-105BNC-105P
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsOvarian NeoplasmsColorectal NeoplasmsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeNew Zealand +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBionomics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBionomics Ltd
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsOvarian NeoplasmsCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A